Drug Trial Radar · NCT06727552
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
131
Actual
Start
Dec 18, 2024
Primary completion
May 6, 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Celldex TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Conditions
- Atopic Dermatitis
Interventions
BarzolvolimabBiological
Subcutaneous Administration
Matching placeboDrug
Subcutaneous Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from Baseline in the weekly average of the daily Peak Pruritus Numerical Rating Scale (PP-NRS) score at Week 16Time frame: From Day 1 (first dose) to Day 113 (week 16)
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Cahaba Dermatology & Skin Health Center, LLC
Birmingham, Alabama
Ohara Aivaz MD Dermatology
Beverly Hills, California
Advanced Dermatology Center - Burbank
Burbank, California
310 Clinical Research
Inglewood, California
Avance Trials
Laguna Niguel, California
LA Universal Research Center, Inc.
Los Angeles, California
UCLA Division of Dermatology
Los Angeles, California
Dynasty Dermatology
Pasadena, California
Acclaim Clinical Research
San Diego, California
FOMAT Medical Research - Allergy, Asthma, & Immunology Medical Group
Ventura, California
Focus Clinical Research
West Hills, California
Direct Helpers Research Center
Hialeah, Florida
International Dermatology Research Inc - Miami
Miami Lakes, Florida
Sarasota Clinical Research
Sarasota, Florida
Well Pharma Medical Research Corporation
South Miami, Florida
Centricity Research Columbus Dermatology
Columbus, Georgia
Georgia Skin and Cancer Clinic
Savannah, Georgia
Treasure Valley Medical Research
Boise, Idaho
Center for Medical Dermatology + Immunology Research
Chicago, Illinois
Sneeze Wheeze and Itch Associates LLC
Normal, Illinois
Equity Medical LLC
Bowling Green, Kentucky
Allergy and Asthma Specialists PSC
Owensboro, Kentucky
Onyx Clinical Research - Michigan
Flint, Michigan
Revival Research Institute, LLC
Troy, Michigan
Excel Clinical Research
Las Vegas, Nevada
Equity Medical, LLC
New York, New York
OptiSkin Medical
New York, New York
Bernstein Clinical Research Center, LLC
Cincinnati, Ohio
Palmetto Clinical Trial Services LLC
Simpsonville, South Carolina
Zenos Clinical Research
Dallas, Texas
Sienna Dermatology
Sugar Land, Texas
Center for Clinical Studies LTD.LLP
Webster, Texas
Jordan Valley Dermatology Center - South Jordan
South Jordan, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.